Imprimis Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1a Burton Hills Blvd Ste 200, Nashville,...Phone Number
(858) 264-2082Website
www.imprimisrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Imprimis Pharmaceuticals
mission of Imprimis Pharmaceuticals is to improve patient health and their quality of life by working with innovative compounding pharmacists and drug developers to commercialize compounded drug formulations. We are also focused on leveraging Accudel, a patented topical drug delivery platform, that enables highly targeted site specific treatment. Why are we focused on topical drug delivery? Because delivering medicines locally to a specific site in the body instead of swallowing a pill, for example, allows for a reduction in problematic side effects often associated with systemic delivery. We believe our focus on compounded drug formulations and topical drug delivery improves patient health and quality of life.Explore more
Imprimis Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imprimis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Imprimis Pharmaceuticals launches new products
Earning: See what the market has to say on Imprimis Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Imprimis Pharmaceuticals
Imprimis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Imprimis Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Imprimis Pharmaceuticals has new funding data
Check out if Imprimis Pharmaceuticals is spiking on competitors!
Check if Imprimis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Imprimis Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Imprimis Pharmaceuticals
Compare insights from companies similar to Imprimis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imprimis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imprimis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imprimis Pharmaceuticals.
Imprimis Pharmaceuticals financials insights
Gather financial insights about Imprimis Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Share Placement
$8M
2015
Other Financing Round
$15M
2016
Share Placement
$9.8M
2017
Debt
$16M
Imprimis Pharmaceuticals Tech Stack
A closer look at the technologies used by Imprimis Pharmaceuticals
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Open Position
Open Position
Imprimis Pharmaceuticals News & Media
ImprimisRx Announces Leadership Changes - GlobeNewswire
Frank Mullery Appointed Chief Executive Officer of ImprimisRx Bridseida Cruz Appointed Head of Quality of ImprimisRx NASHVILLE, Tenn., Oct. 06, 2025 ...OSRX, Inc. Responds to Jury Verdict in Trademark Infringement Case
MISSOULA, Mont.--(BUSINESS WIRE)--OSRX, Inc. today expressed its profound disappointment with the recent jury verdict in the case of ImprimisRx, LLC v. OSRX, Inc. The company believes the decision to be unjust and not based on the facts presented during the trial. Despite this setback, OSRX remains resolute in its commitment to challenge this outcome and address the significant issues that persist. “Leading up to the trial, OSRX won summary judgment on ImprimisRx’s false advertising claims,Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced a favorable jury verdict in the case of ImprimisRx, LLC v. OSRX, Inc. ImprimisRx, a wholly owned subsidiary of Harrow, brought the lawsuit to a jury trial in a San Diego, California, federal court alleging willful acts of trademark infringement against OSRX, Inc. and its related party, Ocular Science, Inc. An eight-person jury in the United States DistrictHarrow Launches Next-Generation Compounded Atropine Formulations
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of its patent-pending, next-generation compounded Atropine formulations, which are now available through Harrow’s wholly owned compounding and mail order pharmacy subsidiary, ImprimisRx. In commenting on the announcement, Mark L. Baum, Chairman and Chief Executive Officer of Harrow, said, “Our mission has always been to help our eyecare professionals addre
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imprimis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
mission of Imprimis Pharmaceuticals is to improve patient health and their quality of life by working with innovative compounding pharmacists and drug developers to commercialize compounded drug formulations. We are also focused on leveraging Accudel, a patented topical drug delivery platform, that enables highly targeted site specific treatment. W... Read More
